Literature DB >> 21701523

Assessment of myocardial ischaemia using tissue Doppler imaging in pseudoexfoliation syndrome.

N Demir1, T Ulus, O E Yucel, E T Kumral, E Singar, H I Tanboga.   

Abstract

PURPOSE: Pseudoexfoliation (PEX) syndrome is characterized by the widespread deposition of abnormal extracellular fibrillary material on many ocular and extraocular tissues. We aimed to investigate the association between PEX syndrome and subclinical myocardial ischaemia, using tissue Doppler echocardiography.
METHODS: Thirty-two patients with pseudoexfoliation syndrome (mean age: 66±9 years, 22 men) and 25 healthy individuals (mean age: 67±8 years, 13 men) were included in the study. Patients with overt coronary artery disease, congestive heart failure, valvular heart disease, cardiomyopathy, and left ventricular hypertrophy were excluded from the study. Tissue Doppler imaging was performed at the septal, lateral, anterior, and inferior mitral annuluses. Differences between the groups were evaluated by the unpaired t-test and the Mann-Whitney U-test, with a P-value of <0.05 considered significant.
RESULTS: Baseline clinical characteristics, two-dimensional, and Doppler echocardiography parameters were similar in the PEX and control groups. Peak systolic velocities at the septal, lateral, anterior, and inferior annuluses were significantly lower in patients with PEX syndrome (P<0.001, 0.01, 0.02, and 0.02, respectively). The early diastolic velocity at the septal annulus, and the ratio of early/late diastolic velocity at the lateral annulus were significantly lower in the study group (P=0.03).
CONCLUSION: PEX syndrome is a common disorder of extracellular matrix. Our data suggest that there may also be an association between PEX syndrome and subclinical myocardial ischaemia in patients who have no signs and symptoms of ischaemia. Thus, we think that ophthalmologists should consider informing their PEX syndrome patients' general practitioners about a possible cardiac risk.

Entities:  

Mesh:

Year:  2011        PMID: 21701523      PMCID: PMC3178234          DOI: 10.1038/eye.2011.145

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  16 in total

Review 1.  Ocular and systemic pseudoexfoliation syndrome.

Authors:  Ursula Schlötzer-Schrehardt; Gottfried O H Naumann
Journal:  Am J Ophthalmol       Date:  2006-05       Impact factor: 5.258

2.  Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation.

Authors:  Kaeng W Lee; Andrew D Blann; Gregory Y H Lip
Journal:  Am Heart J       Date:  2005-10       Impact factor: 4.749

Review 3.  Exfoliation syndrome and exfoliation glaucoma.

Authors:  E Vesti; T Kivelä
Journal:  Prog Retin Eye Res       Date:  2000-05       Impact factor: 21.198

Review 4.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

5.  Assessment of nonuniformity of transmural myocardial velocities by color-coded tissue Doppler imaging: characterization of normal, ischemic, and stunned myocardium.

Authors:  G Derumeaux; M Ovize; J Loufoua; G Pontier; X André-Fouet; A Cribier
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

Review 6.  Exfoliation syndrome.

Authors:  R Ritch; U Schlötzer-Schrehardt
Journal:  Surv Ophthalmol       Date:  2001 Jan-Feb       Impact factor: 6.048

7.  Pseudoexfoliation syndrome and aneurysms of the abdominal aorta.

Authors:  S Schumacher; U Schlötzer-Schrehardt; P Martus; W Lang; G O Naumann
Journal:  Lancet       Date:  2001-02-03       Impact factor: 79.321

8.  Frequency of systemic vascular diseases in patients with primary open-angle glaucoma and exfoliation glaucoma.

Authors:  Ahti Tarkkanen; Antti Reunanen; Tero Kivelä
Journal:  Acta Ophthalmol       Date:  2008-08-08       Impact factor: 3.761

Review 9.  Assessment of myocardial ischemia and viability using tissue Doppler and deformation imaging: the lessons from the experimental studies.

Authors:  H Thibault; G Derumeaux
Journal:  Arch Cardiovasc Dis       Date:  2008-01       Impact factor: 2.340

10.  Pseudoexfoliation syndrome prevalence in Greek patients with cataract and its association to glaucoma and coronary artery disease.

Authors:  G K Andrikopoulos; E K Mela; C D Georgakopoulos; G E Papadopoulos; A N Damelou; D K Alexopoulos; S P Gartaganis
Journal:  Eye (Lond)       Date:  2007-10-12       Impact factor: 3.775

View more
  9 in total

1.  Electroneuromyographic findings in pseudoexfoliation syndrome.

Authors:  Deniz Turgut Coban; Tuncay Cakir; Muhammet Kazim Erol; Gulsum Dogan; Berna Dogan; Meral Bilgilisoy Filiz; Naciye Fusun Toraman
Journal:  Int Ophthalmol       Date:  2017-04-12       Impact factor: 2.031

2.  The Relationship between caffeine and coffee consumption and exfoliation glaucoma or glaucoma suspect: a prospective study in two cohorts.

Authors:  Louis R Pasquale; Janey L Wiggs; Walter C Willett; Jae H Kang
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-21       Impact factor: 4.799

Review 3.  Pseudoexfoliation syndrome and cardiovascular diseases.

Authors:  Georgios K Andrikopoulos; Dimitrios K Alexopoulos; Sotirios P Gartaganis
Journal:  World J Cardiol       Date:  2014-08-26

Review 4.  Ocular Pseudoexfoliation Syndrome Linkage to Cardiovascular Disease.

Authors:  Juan A Siordia; Jimena Franco; Todd R Golden; Bilal Dar
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

5.  Ocular pseudoexfoliation and cardiovascular disease: a national cross-section comparison study.

Authors:  Dustin D French; Curtis E Margo; Lynn E Harman
Journal:  N Am J Med Sci       Date:  2012-10

6.  Paraoxonase 1 (PON1) promoter (-107T/C) and coding region (192Q/R and 55L/M) genetic variations in pseudoexfoliation syndrome and pseudoexfoliative glaucoma risk.

Authors:  Birsen Can Demirdöğen; Canan Koçan Akçin; Ezgi Göksoy; Gizem Yakar; Tuğçe Öztepe; Sinem Demirkaya-Budak; Sinan Oflaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-10       Impact factor: 3.117

Review 7.  Cardiovascular repercussions of the pseudoexfoliation syndrome.

Authors:  Vasiliki Katsi; Antonios N Pavlidis; Manolis S Kallistratos; Athanasios Fitsios; Athanasios Bratsas; Dimitris Tousoulis; Christodoulos Stefanadis; Athanasios J Manolis; Ioannis Kallikazaros
Journal:  N Am J Med Sci       Date:  2013-08

Review 8.  Ocular pseudoexfoliation syndrome and vascular disease: a systematic review and meta-analysis.

Authors:  Wei Wang; Miao He; Minwen Zhou; Xiulan Zhang
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

9.  The frequency of exfoliation syndrome in the central anatolia region of Turkey.

Authors:  Raşit Kılıç; Hafize Sezer; Sebile Ü Comçalı; Serdar Bayraktar; Gökay Göktolga; Yasin Cakmak; Abdi B Cetin; Tongabay Cumurcu
Journal:  J Ophthalmol       Date:  2014-06-17       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.